AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
RAPID GANCICLOVIR SUSCEPTIBILITY ASSAY USING FLOW-CYTOMETRY FOR HUMANCYTOMEGALOVIRUS CLINICAL ISOLATES
Authors: MCSHARRY JJ LURAIN NS DRUSANO GL LANDAY AL NOTKA M OGORMAN MRG WEINBERG A SHAPIRO HM REICHELDERFER PS CRUMPACKER CS
Citation: Jj. Mcsharry et al., RAPID GANCICLOVIR SUSCEPTIBILITY ASSAY USING FLOW-CYTOMETRY FOR HUMANCYTOMEGALOVIRUS CLINICAL ISOLATES, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2326-2331
SORIVUDINE VERSUS ACYCLOVIR FOR TREATMENT OF DERMATOMAL HERPES-ZOSTERIN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS FROM A RANDOMIZED, CONTROLLED CLINICAL-TRIAL
Authors: GNANN JW CRUMPACKER CS LALEZARI JP SMITH JA TYRING SK BAUM KF BORUCKI MJ JOSEPH WP MERTZ GJ STEIGBIGEL RT CLOUD GA SOONG SJ SHERRILL LC DEHERTOGH DA WHITLEY RJ
Citation: Jw. Gnann et al., SORIVUDINE VERSUS ACYCLOVIR FOR TREATMENT OF DERMATOMAL HERPES-ZOSTERIN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS FROM A RANDOMIZED, CONTROLLED CLINICAL-TRIAL, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1139-1145
THE BIS-AZO COMPOUND FP-21399 INHIBITS HIV-1 REPLICATION BY PREVENTING VIRAL ENTRY
Authors: ZHANG JL CHOE H DEZUBE BJ FARZAN M SHARMA PL ZHOU XC CHEN LB ONO M GILLIES S WU YM SODROSKI JG CRUMPACKER CS
Citation: Jl. Zhang et al., THE BIS-AZO COMPOUND FP-21399 INHIBITS HIV-1 REPLICATION BY PREVENTING VIRAL ENTRY, Virology, 244(2), 1998, pp. 530-541
ATTENUATED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A DIDANOSINE-SELECTED REVERSE-TRANSCRIPTASE MUTATION (VOL 71, PG 8850, 1997)
Authors: SHARMA PL CRUMPACKER CS
Citation: Pl. Sharma et Cs. Crumpacker, ATTENUATED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A DIDANOSINE-SELECTED REVERSE-TRANSCRIPTASE MUTATION (VOL 71, PG 8850, 1997), Journal of virology, 72(4), 1998, pp. 3504-3504
EXPRESSION OF THE CD8-ALPHA-BETA-HETERODIMER ON CD8(-LYMPHOCYTES IN PERIPHERAL-BLOOD LYMPHOCYTES OF HUMAN IMMUNODEFICIENCY VIRUS(-) AND HUMAN IMMUNODEFICIENCY VIRUS(+) INDIVIDUALS() T)
Authors: SCHMITZ JE FORMAN MA LIFTON MA CONCEPCION O REIMANN KA CRUMPACKER CS DALEY JF GELMAN RS LETVIN NL
Citation: Je. Schmitz et al., EXPRESSION OF THE CD8-ALPHA-BETA-HETERODIMER ON CD8(-LYMPHOCYTES IN PERIPHERAL-BLOOD LYMPHOCYTES OF HUMAN IMMUNODEFICIENCY VIRUS(-) AND HUMAN IMMUNODEFICIENCY VIRUS(+) INDIVIDUALS() T), Blood, 92(1), 1998, pp. 198-206
TOPOTECAN INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION THROUGH A TOPOISOMERASE-INDEPENDENT MECHANISM IN A CELL-LINE WITH ALTERED TOPOISOMERASE-I
Authors: ZHANG JL SHARMA PL LI CJ DEZUBE BJ PARDEE AB CRUMPACKER CS
Citation: Jl. Zhang et al., TOPOTECAN INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION THROUGH A TOPOISOMERASE-INDEPENDENT MECHANISM IN A CELL-LINE WITH ALTERED TOPOISOMERASE-I, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 977-981
ATTENUATED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A DIDANOSINE-SELECTED REVERSE-TRANSCRIPTASE MUTATION
Authors: SHARMA PL CRUMPACKER CS
Citation: Pl. Sharma et Cs. Crumpacker, ATTENUATED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A DIDANOSINE-SELECTED REVERSE-TRANSCRIPTASE MUTATION, Journal of virology, 71(11), 1997, pp. 8846-8851
THE EFFECT OF TENIDAP ON CYTOKINES, ACUTE-PHASE PROTEINS, AND VIRUS LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED PATIENTS - CORRELATION BETWEEN PLASMA HIV-1 RNA AND PROINFLAMMATORY CYTOKINE LEVELS
Authors: DEZUBE BJ LEDERMAN MM CHAPMAN B GEORGES DL DOGON AL MUDIDO P REISLISHING J CHENG SL SILBERMAN SL CRUMPACKER CS
Citation: Bj. Dezube et al., THE EFFECT OF TENIDAP ON CYTOKINES, ACUTE-PHASE PROTEINS, AND VIRUS LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED PATIENTS - CORRELATION BETWEEN PLASMA HIV-1 RNA AND PROINFLAMMATORY CYTOKINE LEVELS, The Journal of infectious diseases, 176(3), 1997, pp. 807-810
THE INTERLEUKIN-2 FUSION PROTEIN, DAB(389)IL-2, INHIBITS THE DEVELOPMENT OF INFECTIOUS VIRUS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: ZHANG LJ WATERS CA POISSON LR ESTIS LF CRUMPACKER CS
Citation: Lj. Zhang et al., THE INTERLEUKIN-2 FUSION PROTEIN, DAB(389)IL-2, INHIBITS THE DEVELOPMENT OF INFECTIOUS VIRUS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, The Journal of infectious diseases, 175(4), 1997, pp. 790-794
A PHASE-I STUDY OF THE SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF COMBINATION DIDANOSINE AND RIBAVIRIN IN PATIENTS WITH HIV-1 DISEASE
Authors: JAPOUR AJ LERTORA JJ MEEHAN PM ERICE A CONNOR JD GRIFFITH BP CLAX PA HOLDENWILTSE J HUSSEY S WALESKY M COONEY E POLLARD R TIMPONE J MCLAREN C JOHANNESON N WOOD K BOOTH DK BASSIAKOS Y CRUMPACKER CS
Citation: Aj. Japour et al., A PHASE-I STUDY OF THE SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF COMBINATION DIDANOSINE AND RIBAVIRIN IN PATIENTS WITH HIV-1 DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 13(3), 1996, pp. 235-246
EFFECT OF FOSCARNET ON QUANTITIES OF CYTOMEGALOVIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS IN BLOOD OF PERSONS WITH AIDS
Authors: BALFOUR HH FLETCHER CV ERICE A HENRY WK ACOSTA EP SMITH SA HOLM MA BOIVIN G SHEPP DH CRUMPACKER CS EATON CA MARTINMUNLEY SS
Citation: Hh. Balfour et al., EFFECT OF FOSCARNET ON QUANTITIES OF CYTOMEGALOVIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS IN BLOOD OF PERSONS WITH AIDS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2721-2726
AZT-RELATED MUTATION LYS70ARG IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS DECREASE SUSCEPTIBILITY TO DDATP IN IN-VITRO RT INHIBITION ASSAY (VOL 223, PG 365, 1996)
Authors: SHARMA PL CHATIS PA DOGON AL MAYERS DL MCCUTCHAN FE PAGE C CRUMPACKER CS
Citation: Pl. Sharma et al., AZT-RELATED MUTATION LYS70ARG IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS DECREASE SUSCEPTIBILITY TO DDATP IN IN-VITRO RT INHIBITION ASSAY (VOL 223, PG 365, 1996), Virology, 225(2), 1996, pp. 428-428
AZT-RELATED MUTATION LYS70ARG IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS DECREASE IN SUSCEPTIBILITY TO DDATP IN IN-VITRO RT INHIBITION ASSAY
Authors: SHARMA PL CHATIS PA DOGON AL MAYERS DL MCCUTCHAN FE PAGE C CRUMPACKER CS
Citation: Pl. Sharma et al., AZT-RELATED MUTATION LYS70ARG IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS DECREASE IN SUSCEPTIBILITY TO DDATP IN IN-VITRO RT INHIBITION ASSAY, Virology, 223(2), 1996, pp. 365-369
DRUG-THERAPY - GANCICLOVIR
Authors: CRUMPACKER CS
Citation: Cs. Crumpacker, DRUG-THERAPY - GANCICLOVIR, The New England journal of medicine, 335(10), 1996, pp. 721-729
ASSOCIATION OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVEL WITH RISK OF CLINICAL PROGRESSION IN PATIENTS WITH ADVANCED INFECTION
Authors: COOMBS RW WELLES SL HOOPER C REICHELDERFER PS DAQUILA RT JAPOUR AJ JOHNSON VA KURITZKES DR RICHMAN DD KWOK S TODD J JACKSON JB DEGRUTTOLA V CRUMPACKER CS KAHN J
Citation: Rw. Coombs et al., ASSOCIATION OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVEL WITH RISK OF CLINICAL PROGRESSION IN PATIENTS WITH ADVANCED INFECTION, The Journal of infectious diseases, 174(4), 1996, pp. 704-712
A RAPID, DIRECT TEST FOR ZIDOVUDINE SUSCEPTIBILITY IN CLINICAL ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) FROM INFECTED CHILDREN
Authors: LAN Y JAPOUR AJ KIM S WELLES SL CRUMPACKER CS COOPER E ALATTAR I MCINTOSH K
Citation: Y. Lan et al., A RAPID, DIRECT TEST FOR ZIDOVUDINE SUSCEPTIBILITY IN CLINICAL ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) FROM INFECTED CHILDREN, Clinical and diagnostic virology, 3(3), 1995, pp. 259-271
ANTIVIRAL RESISTANCE IN CLINICAL-PRACTICE
Authors: KIMBERLIN DW CRUMPACKER CS STRAUS SE BIRON KK DREW WL HAYDEN FG MCKINLAY M RICHMAN DD WHITLEY RJ
Citation: Dw. Kimberlin et al., ANTIVIRAL RESISTANCE IN CLINICAL-PRACTICE, Antiviral research, 26(4), 1995, pp. 423-438
HIGH-DOSE PENTOXIFYLLINE IN PATIENTS WITH AIDS - INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION
Authors: DEZUBE BJ LEDERMAN MM SPRITZLER JG CHAPMAN B KORVICK JA FLEXNER C DANDO S MATTIACCI MR AHLERS CM ZHANG L NOVICK WJ KASDAN P FAHEY JL PARDEE AB CRUMPACKER CS
Citation: Bj. Dezube et al., HIGH-DOSE PENTOXIFYLLINE IN PATIENTS WITH AIDS - INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION, The Journal of infectious diseases, 171(6), 1995, pp. 1628-1632
PREVALENCE AND CLINICAL-SIGNIFICANCE OF ZIDOVUDINE RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATED FROM PATIENTS AFTER LONG-TERM ZIDOVUDINE TREATMENT
Authors: JAPOUR AJ WELLES S DAQUILA RT JOHNSON VA RICHMAN DD COOMBS RW REICHELDERFER PS KAHN JO CRUMPACKER CS KURITZKES DR
Citation: Aj. Japour et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF ZIDOVUDINE RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATED FROM PATIENTS AFTER LONG-TERM ZIDOVUDINE TREATMENT, The Journal of infectious diseases, 171(5), 1995, pp. 1172-1179
DETECTION OF HUMAN CYTOMEGALOVIRUS DNA, RNA, AND ANTIBODY IN NORMAL DONOR BLOOD
Authors: ZHANG LJ HANFF P RUTHERFORD C CHURCHILL WH CRUMPACKER CS
Citation: Lj. Zhang et al., DETECTION OF HUMAN CYTOMEGALOVIRUS DNA, RNA, AND ANTIBODY IN NORMAL DONOR BLOOD, The Journal of infectious diseases, 171(4), 1995, pp. 1002-1006
ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE
Authors: DOLIN R AMATO DA FISCHL MA PETTINELLI C BELTANGADY M LIOU SH BROWN MJ CROSS AP HIRSCH MS HARDY WD MILDVAN D BLAIR DC POWDERLY WG PARA MF FIFE KH STEIGBIGEL RT SMALDONE L CRUMPACKER CS COOLEY T MITSUYASO RT JOHN R SANDERS C REITMAN D HEWITT R REICHMAN RC GELB LD MCGUIRE ML JONES M NEIDIG JL ZWICKL B HARTMAN PB ROARKE ME BURK RA FUHRER J SOMOGYI KA SEPKOWITZ K TELZAK EE MCAULIFFE VJ VALENTINE FT VASQUEZ M MERIGAN TC KATZENSTEIN D FESSELL J HAVLIR DV RICHMAN DD SPECTOR SA KAHN JO JOHNSON L COLEMAN R HO M MCMAHON D PAZIN G ANTONISKIS D MCNAMARA B DIAMOND D COLLIER AC PARADISE MA WALD A DEPAOLISJONES A HENRY K WASKIN HA HYSLOP NE MUSHATT DM ZACHARY JA SOEIRO R HARRIS C ZINGMAN B GIORDANO MF SLEDZ S MURRAY HW CAREY JT DAVIS TL BAGBY B KESSLER HA MURPHY RL HIRSCHTICK RE CHEESEMAN SH LAI KK FAIRCHILD PG EHMANN WC ZURLO JJ MILLARD R TROIANI L HEGGEN AA VANDERHORST CM MCKINLEY GF GRIECO MH KOLATCH BR GOLDSMITH JC GOMPERTS ED WOODS LM GRUE L MAYJO K BECKER RL JAYAWEERA DT ROLFE L COLE J JERMANO J
Citation: R. Dolin et al., ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE, Archives of internal medicine, 155(9), 1995, pp. 961-974
ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY
Authors: DAQUILA RT JOHNSON VA WELLES SL JAPOUR AJ KURITZKES DR DEGRUTTOLA V REICHELDERFER PS COOMBS RW CRUMPACKER CS KAHN JO RICHMAN DD
Citation: Rt. Daquila et al., ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY, Annals of internal medicine, 122(6), 1995, pp. 401-408
CRITERIA FOR THE DIAGNOSIS OF INFECTIVE ENDOCARDITIS
Authors: VONREYN CF ARBEIT RD FRIEDLAND GH CRUMPACKER CS
Citation: Cf. Vonreyn et al., CRITERIA FOR THE DIAGNOSIS OF INFECTIVE ENDOCARDITIS, Clinical infectious diseases, 19(2), 1994, pp. 368-369
DIDEOXYNUCLEOSIDE RESISTANCE EMERGES WITH PROLONGED ZIDOVUDINE MONOTHERAPY
Authors: MAYERS DL JAPOUR AJ ARDUINO JM HAMMER SM REICHMAN R WAGNER KF CHUNG R LANE J CRUMPACKER CS MCLEOD GX BECKETT LA ROBERTS CR WINSLOW D BURKE D RUIZ N FUJIMARAJUSTICE M KERNOZEK P KOCH J BREWER C HICKS C SHELLIE ME LORIZLIM L SMALLS C HAMILTON A MCCUTCHAN F SANDERSBUELL E WEISLOW O FOWLER A LANE J MERRITT L
Citation: Dl. Mayers et al., DIDEOXYNUCLEOSIDE RESISTANCE EMERGES WITH PROLONGED ZIDOVUDINE MONOTHERAPY, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 307-314
RECURRENCE AND RESISTANCE PATTERNS OF HERPES-SIMPLEX VIRUS FOLLOWING CESSATION OF GREATER-THAN-OR-EQUAL-TO-6 YEARS OF CHRONIC SUPPRESSION WITH ACYCLOVIR
Authors: FIFE KH CRUMPACKER CS MERTZ GJ HILL EL BOONE GS BAKER D BLYTHE J ERON L FROST P GOLDBERG L HERNDON J KAPLOWITZ L KAUFMAN R KURTZ T MILLS J RABINOVICH S VANDERHORST C CONANT M
Citation: Kh. Fife et al., RECURRENCE AND RESISTANCE PATTERNS OF HERPES-SIMPLEX VIRUS FOLLOWING CESSATION OF GREATER-THAN-OR-EQUAL-TO-6 YEARS OF CHRONIC SUPPRESSION WITH ACYCLOVIR, The Journal of infectious diseases, 169(6), 1994, pp. 1338-1341
Risultati: 1-25 | 26-29